Similar Papers

Paper Title
Journal
Date
Author
Pharmacokinetics of Intravenous Conivaptan in Subjects With Hepatic or Renal Impairment
Michael J Roy ... James J Keirns
Clinical Pharmacokinetics | VOL. 52
Michael J Roy, et. al.Michael J Roy ... James J Keirns
01 Mar 2013
Influence of mild and moderate hepatic impairment on axitinib pharmacokinetics.
Michael A Tortorici ... Christine W Alvey
Investigational New Drugs | VOL. 29
Michael A Tortorici, et. al.Michael A Tortorici ... Christine W Alvey
02 Jul 2010
Asenapine Pharmacokinetics in Hepatic and Renal Impairment
Pierre Peeters ... Edwin Spaans
Clinical Pharmacokinetics | VOL. 50
Pierre Peeters, et. al.Pierre Peeters ... Edwin Spaans
01 Jul 2011
Pharmacokinetics of linagliptin in subjects with hepatic impairment
Ulrike Graefe‐Mody ... Lisa Waldhauser
British Journal of Clinical Pharmacology | VOL. 74
Ulrike Graefe‐Mody, et. al.Ulrike Graefe‐Mody ... Lisa Waldhauser
11 Jun 2012
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the rheumatic diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
20 Dec 2024
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the Rheumatic Diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
19 Dec 2024
Contents
-
Annals of the Rheumatic Diseases | VOL. 83
--
01 Dec 2024
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults
Elizabeth M Winter ... Anne T Leerling
Annals of the Rheumatic Diseases | VOL. -
Elizabeth M Winter, et. al.Elizabeth M Winter ... Anne T Leerling
28 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.